Affimed NV Sustainability Reports
Affimed N.V. is a clinical-stage biopharmaceutical company that discovers and develops targeted immunotherapies for cancer. Its proprietary platform specializes in engineering innate cell engager molecules that direct the body's natural immune cells to destroy tumors.
Sector: Manufacturing
Country: Germany
Exchange: OTC Markets
LEI: 8945008KK4QRBYT6R544
5 reports from 2016 to 2022
